It can be expected that the upregulation of a methyltransferase such as EZH2 by mutp53 may result in methylation changes of histones and in aberrant regulation of gene transcription, impacting, for example, the expression of tumor suppressors, with important consequences on cancer cell biology. The gene discussed is EZH2; the disease is cancer.